Aquestive Therapeutics
Develops PharmFilm oral medicines and manufactures licensed films for global partners.
$5.02
After-hours close0.00 (0.00%)
At close$5.02(−2.71%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 57.64%72.32M sharesInsiders 2.39%3.00M sharesOther 39.97%50.15M shares
Shares outstanding 125.47M · Float 114.59M · 91.3% free float
Institutions13F, as of Jun 30, 2026
195 holders · 72.32M shares · 28 new positions · 98 increased · 43 reduced · 20 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Bratton Capital Management, L.P. | 9.81M | 7.82% | 0 | Aug 11, 2026 |
| BlackRock, Inc. | 8.07M | 6.43% | +560.3K | Aug 7, 2026 |
| RTW Investments, LP | 7.43M | 5.92% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 4.58M | 3.65% | +140.8K | Aug 13, 2026 |
| Federated Hermes, Inc. | 3.11M | 2.48% | +172.2K | Aug 12, 2026 |
| State Street Corp | 2.93M | 2.33% | +381.8K | Aug 7, 2026 |
| Geode Capital Management, LLC | 2.62M | 2.09% | +214.7K | Aug 12, 2026 |
| Samsara Biocapital, LLC | 2.50M | 1.99% | 0 | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Bratton Douglas K | 11.10% | 10.08M | 13G | Feb 13, 2025 ↗ |
| BlackRock, Inc. | 5.30% | 6.43M | 13G | Oct 17, 2025 ↗ |
| RTW Investments, LP | 5.20% | 6.25M | 13G | Nov 14, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Daniel Barber | director, officer: President and CEO | 585.6K | 0.47% | Aug 18, 2026 |
| Stephen Wargacki | officer: Chief Science Officer | 343.6K | 0.27% | Mar 11, 2025 |
| A. Ernest Jr Toth | officer: Chief Financial Officer | 283.5K | 0.23% | May 7, 2026 |
| Carl N. Kraus | officer: Chief Medical Officer | 282.5K | 0.23% | Oct 17, 2025 |
| Peter E. Boyd | officer: Chief People Officer | 281.7K | 0.22% | May 7, 2026 |
| Melina Cioffi | officer: SVP, Regulatory Affairs | 273.2K | 0.22% | May 18, 2026 |
| Sherry Korczynski | officer: Chief Commercial Officer | 235.7K | 0.19% | Aug 17, 2026 |
| Lori J. Braender | officer: Corporate Secretary | 231.0K | 0.18% | May 11, 2026 |
| Cassie Jung | officer: Chief Operating Officer | 202.2K | 0.16% | May 7, 2026 |
| Thomas A. Zalewski | officer: Chief Legal Officer | 100.0K | 0.08% | May 19, 2026 |
10 ten-percent owners hold 970.8K shares by Form 4, outside the officers-and-directors figure above · 1 person has not refiled in the last 18 months (980.7K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 17, 2026 | Daniel Barberdirector, officer: President and CEO | Sale | 25,000 | $4.29 | 585,574 |
| Jul 16, 2026 | Daniel Barberofficer: President and CEO | Sale | 20,369 | $4.00 | 610,574 |
| Jul 15, 2026 | Daniel Barberofficer: President and CEO | Sale | 4,631 | $4.03 | 630,943 |
| Jun 23, 2026 | Julie Kropdirector | Sale | 25,000 | $5.02 | 0 |
| Jun 15, 2026 | Daniel Barberofficer: President and CEO | Sale | 25,000 | $4.16 | 635,574 |
| May 15, 2026 | Daniel Barberofficer: President and CEO | Sale | 8,257 | $4.29 | 660,574 |
| Mar 10, 2026 | Cassie Jungofficer: Chief Operating Officer | Sale | 45,791 | $4.17 | 274,980 |
| Mar 10, 2026 | Sherry Korczynskiofficer: Chief Commercial Officer | Sale | 15,741 | $4.17 | 241,117 |
| Mar 10, 2026 | A. Ernest Jr Tothofficer: Chief Financial Officer | Sale | 58,254 | $4.17 | 376,112 |
| Mar 10, 2026 | Melina Cioffiofficer: SVP, Regulatory Affairs | Sale | 25,311 | $4.17 | 274,867 |
CongressHouse and Senate disclosures
Not reported.